LI
MDGL icon

LRI Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

LRI Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76K Hold
7
– – ﹤0.01% 1186
2026
Q1 		$3.66K Buy
+7
New +$3.34K ﹤0.01% 1164

Other funds holding MDGL

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
WC
Waterloo Capital Austin, Texas $1.78B AUM 27.25% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LRI Investments's MDGL Position: Q2 2026 in Review

LRI Investments held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 7 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

LRI Investments first reported a position in MDGL in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • LRI Investments held 7 shares of Madrigal Pharmaceuticals worth $3.76K as of Q2 2026.
  • LRI Investments left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1186 holding.
  • LRI Investments first reported a position in Madrigal Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.